Role of imiquimod and parenteral meglumine antimoniate in the initial treatment of cutaneous leishmaniasis

MLA

Arevalo, Iracema, et al. “Role of Imiquimod and Parenteral Meglumine Antimoniate in the Initial Treatment of Cutaneous Leishmaniasis.” Clinical Infectious Diseases, vol. 44, no. 12, June 2007, p. 1549. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.165753425&authtype=sso&custid=ns315887.

APA

Arevalo, I., Tulliano, G., Quispe, A., Spaeth, G., Matlashewski, G., Llanos-Cuentas, A., & Pollack, H. (2007). Role of imiquimod and parenteral meglumine antimoniate in the initial treatment of cutaneous leishmaniasis. Clinical Infectious Diseases, 44(12), 1549.

Chicago

Arevalo, Iracema, Gianfranco Tulliano, Ana Quispe, Gerald Spaeth, Greg Matlashewski, Alejandro Llanos-Cuentas, and Henry Pollack. 2007. “Role of Imiquimod and Parenteral Meglumine Antimoniate in the Initial Treatment of Cutaneous Leishmaniasis.” Clinical Infectious Diseases 44 (12): 1549. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.165753425&authtype=sso&custid=ns315887.